<em>EGFR </em>mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?

Abstract

<i>EGFR</i> mutation in SCC of the lung predicts a better outcome if the patient is given TKI, but it may be inferior to the outcomes seen in <i>EGFR</i>-positive adenocarcinomas treated with TKI.